These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19632582)
41. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality. Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355 [TBL] [Abstract][Full Text] [Related]
42. Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products. Coppage M; Baker M; Fialkow L; Meehan D; Gettings K; Chen L; Massey HT; Blumberg N Hum Immunol; 2009 Jun; 70(6):413-6. PubMed ID: 19275923 [TBL] [Abstract][Full Text] [Related]
43. Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients. Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J J Am Coll Cardiol; 2013 Dec; 62(24):2308-15. PubMed ID: 23994416 [TBL] [Abstract][Full Text] [Related]
44. Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device. Goffinet J; St Pierre Schneider B Heart Lung; 2002; 31(2):122-30; quiz, 131-2. PubMed ID: 11910387 [TBL] [Abstract][Full Text] [Related]
45. [Preparation of highly HLA-sensitized patient for heart transplantation: first documented case in Croatia]. Gavranić BB; Basić-Jukić N; Ratković-Gusić I; Martinez N; Ivancan V; Kes P Acta Med Croatica; 2011; 65(4):301-4. PubMed ID: 22359900 [TBL] [Abstract][Full Text] [Related]
46. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
47. Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach. Uriel MH; Clerkin KJ; Takeda K; Naka Y; Sayer GT; Uriel N; Topkara VK J Heart Lung Transplant; 2023 Jan; 42(1):124-133. PubMed ID: 36272893 [TBL] [Abstract][Full Text] [Related]
48. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. Anjum A; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Civitello AB; Etheridge WB; Delgado RM; Simpson L; George JK; Nair AP; Frazier OH; Morgan JA J Artif Organs; 2018 Sep; 21(3):285-292. PubMed ID: 29766321 [TBL] [Abstract][Full Text] [Related]
49. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation. Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353 [TBL] [Abstract][Full Text] [Related]
50. Impact of age on outcomes following continuous-flow left ventricular assist device implantation. Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085 [TBL] [Abstract][Full Text] [Related]
51. Outcomes in patients receiving HeartMate II versus HVAD left ventricular assist device as a bridge to transplantation. Sabashnikov A; Mohite PN; Zych B; Popov AF; Fatullayev J; Zeriouh M; Hards R; Sáez DG; Capoccia M; Choi YH; Wahlers T; De Robertis F; Bahrami T; Amrani M; Simon AR Transplant Proc; 2014 Jun; 46(5):1469-75. PubMed ID: 24935315 [TBL] [Abstract][Full Text] [Related]
52. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934 [TBL] [Abstract][Full Text] [Related]
56. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717 [TBL] [Abstract][Full Text] [Related]
57. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854 [TBL] [Abstract][Full Text] [Related]
58. HeartMate left ventricular assist device as bridge to heart transplantation. Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070 [TBL] [Abstract][Full Text] [Related]
59. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation. Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448 [TBL] [Abstract][Full Text] [Related]
60. More than 20 years' experience of left ventricular assist device implantation at a non-transplant Centre. Holmberg E; Ahn H; Peterzén B Scand Cardiovasc J; 2017 Dec; 51(6):293-298. PubMed ID: 29029567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]